Predictive Oncology Inc. Annual Operating Income (Loss) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Predictive Oncology Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • Predictive Oncology Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.2M, a 38.6% increase year-over-year.
  • Predictive Oncology Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$10.9M, a 9.72% increase year-over-year.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2024 was -$10.9M, a 9.72% increase from 2023.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2023 was -$12.1M, a 53.5% increase from 2022.
  • Predictive Oncology Inc. annual Operating Income (Loss) for 2022 was -$26M, a 27.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$10.9M +$1.18M +9.72% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$12.1M +$13.9M +53.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$26M -$5.61M -27.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$20.4M +$4.93M +19.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 -$25.4M -$2.72M -12% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$22.6M -$14.8M -188% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 -$7.86M Jan 1, 2018 Dec 31, 2018 10-K 2020-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.